Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506).
Kramer
M R
MR
Pulmonary Institute, Hadassah University Hospital, Jerusalem, Israel.
Merin
G
G
Rudis
E
E
Bar
I
I
Nesher
T
T
Bublil
M
M
Milgalter
E
E
D000935:Antifungal Agents / Q000008:administration & dosage* / Q000191:economics; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000191:economics / Q000517:prevention & control*; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017964:Itraconazole / Q000008:administration & dosage* / Q000191:economics; D016040:Lung Transplantation; D008297:Male; D009181:Mycoses / Q000191:economics / Q000209:etiology / Q000517:prevention & control*; D016559:Tacrolimus / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D017964:Itraconazole; D016572:Cyclosporine; D016559:Tacrolimus